The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
Abstract Background It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes...
Spremljeno u:
Glavni autori: | , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Wiley,
2021-06-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |